Beijing Leadman Biochemistry Co.,Ltd. (SHE:300289)
China · Delayed Price · Currency is CNY 6.00
-0.15 (-2.44%)
Nov 13, 2026, 3:04 PM CST
SHE:300289 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 485.94 | 326.31 | 370.23 | 461.55 | 705.98 | 564.06 |
Revenue Growth | 42.65% | -11.86% | -19.79% | -34.62% | 25.16% | 19.63% |
Gross Profit Gross Profit Growth | 262.57 | 151.18 | 183.88 | 263.55 | 298.2 | 294.28 |
Operating Income Operating Income Growth | 4.55 | -32.84 | -35.83 | 20.02 | 17.94 | 66.62 |
Net Income Net Income Growth | -8.91 | -22.98 | -75.1 | 15.34 | -56.27 | 22.42 |
Earnings Per Share EPS Growth | -0.02 | -0.04 | -0.14 | 0.03 | -0.10 | 0.05 |
EPS Growth | - | - | - | - | - | - |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Biological and Pharmaceutical Products Biological and Pharmaceutical Products Growth | 285.64 | 336.32 | 421.98 | 675.94 | 540.94 |
Property Leasing Property Leasing Growth | 38.53 | 33.26 | 38.26 | 29.32 | 21.68 |
Serve Serve Growth | 2.14 | 0.64 | 1.32 | 0.72 | 1.44 |
Total Total Growth | 326.31 | 370.23 | 461.55 | 705.98 | 564.06 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 574.79 | 902.77 | 890.41 | 855.32 | 798.81 | 928.6 |
Total Debt Total Debt Growth | 982.81 | 4.2 | 4.83 | 8.95 | 11.84 | 13.13 |
Net Cash (Debt) Net Cash Growth | -408.01 | 898.57 | 885.58 | 846.37 | 786.97 | 915.47 |
Net Cash Growth | - | 1.47% | 4.63% | 7.55% | -14.04% | 192.03% |
Net Cash Per Share Net Cash Per Share Growth | -0.75 | 1.65 | 1.63 | 1.56 | 1.40 | 2.04 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 75.16 | 29.16 | 62.41 | 130.8 | 108.93 | 119.06 |
Capital Expenditures CapEx Growth | -33.44 | -17.59 | -29.23 | -18.69 | -39.12 | -44.5 |
Free Cash Flow Free Cash Flow Growth | 41.72 | 11.57 | 33.18 | 112.11 | 69.81 | 74.56 |
Free Cash Flow Growth | 407.21% | -65.12% | -70.40% | 60.58% | -6.36% | -30.43% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 54.03% | 46.33% | 49.67% | 57.10% | 42.24% | 52.17% |
Operating Margin | 0.94% | -10.06% | -9.68% | 4.34% | 2.54% | 11.81% |
Pretax Margin | 3.39% | -5.38% | -19.76% | 5.32% | -3.56% | 10.42% |
Profit Margin | -1.83% | -7.04% | -20.29% | 3.32% | -7.97% | 3.98% |
FCF Margin | 8.59% | 3.55% | 8.96% | 24.29% | 9.89% | 13.22% |
Fiscal Year | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.010 | - | 0.020 |
Dividend Per Share Growth | - | - | - |
Dividend Yield | 0.16% | - | 0.25% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | - | 218.14 | - | 195.82 |
Forward PE | - | 30.00 | 30.00 | 30.00 | 30.00 | 30.00 |
P/FCF Ratio | 78.23 | 327.59 | 80.34 | 29.84 | 44.88 | 58.88 |
PS Ratio | 6.72 | 11.62 | 7.20 | 7.25 | 4.44 | 7.78 |